KLRK1 and neoplasm: Traditional cytotoxic therapies potentiate CAR-NK efficacy through immunogenic modulation – radiotherapy-induced DNA damage upregulates NKG2D ligands while chemotherapy depletes immunosuppressive myeloid populations, collectively enhancing tumor visibility and NK cell infiltration (58).